Is Align Technology (ALGN) Below Fair Value After Its Patent Win?
Align Technology has seen its share price move around in recent years, yet the real story many investors are watching is whether the current US$155.51 level lines up with the cash the business can generate over time. With a Discounted Cash Flow (DCF) estimate available, the question is how closely that intrinsic value tracks where the stock trades today.
- The share price has fallen 75.4% over the past 5 years, which puts the spotlight squarely on whether the existing cash flow profile can support even the current level.
- A recent patent victory in Europe over a rival clear aligner maker may support future cash flows by helping Align Technology protect pricing power and defend Invisalign volumes in key markets.
- Prefer to judge Align Technology on earnings? See why Align Technology's 26.7x P/E tells a different valuation story.
The issue now is whether Align Technology's present market value is adequately supported by the cash flows implied in its intrinsic value estimate.
If you want a simple yardstick for Align Technology's patent-protected cash flows, compare this setup with companies in the same bracket using 29 high quality undervalued stocks.
Does Align Technology Look Undervalued on Cash Flow?
The Discounted Cash Flow (DCF) model here focuses on the cash Align Technology can generate for shareholders over time. On the latest twelve month view, the group produced roughly $639 million of free cash flow, and the projections used in this DCF point to growing annual cash generation rather than a shrinking stream.
Analysts and model extensions see free cash flow rising into the 2030s, which implies a business that is treated as a long term compounder rather than a turnaround. Because that cash flow path sits substantially above what the current US$155.51 share price implies, the DCF output suggests the market is putting a wide discount on Align Technology's cash generation. The recent European patent win against Angelalign supports that picture, because stronger intellectual property protection can help the company defend those future cash flows in its key clear aligner markets. Find out what Align Technology could be worth using our Discounted Cash Flow (DCF) estimate.
The Align Technology Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for Align Technology pick up where this valuation puzzle leaves off by spelling out what future growth, profitability and earnings paths would need to look like for the stock to trade well above or well below today's level, and they sit on Simply Wall St's Community page. Rather than focusing on a single P/E, DCF output or earnings multiple, each narrative lays out the assumptions behind its fair value view so you can compare those expectations with actual results as they are reported over time.
Community views on Align Technology are split between investors who see more upside in the current setup and those who think expectations already look full.
Bull case: 22% undervalued
"The current valuation implies that Align Technology shares do not fully reflect the company’s margin expansion plans, clear aligner volumes, and commitment to significant share repurchases…"
Discover why this Narrative puts Align Technology at 22% undervalued.
Bear case: roughly fairly valued
"Inflation, discretionary spending pressure, and rising competition are testing whether premium orthodontics can sustain growth without sacrificing margins…"
Explore why this Narrative puts Align Technology at roughly fairly valued.
One more piece of the Align Technology story you should not skip
Valuation only tells part of the Align Technology story, because internal checks have also highlighted specific risk flags that investors may want to weigh before leaning on the numbers alone. Take a closer look at 1 warning sign before settling on a valuation.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com